Nichi-Iko Pharmaceutical - M&A Summary and Business Overview

Medical ProductsCompany

Nichi-Iko Pharmaceutical M&A Summary

Nichi-Iko Pharmaceutical has acquired 1 company.

Nichi-Iko Pharmaceutical’s largest acquisition to date was in 2016, when it acquired Sagent Pharmaceuticals for $736M. Nichi-Iko Pharmaceutical has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).

Nichi-Iko Pharmaceutical Business Overview

Where is Nichi-Iko Pharmaceutical headquartered?

Nichi-Iko Pharmaceutical is headquartered in Toyama, Japan.

What is Nichi-Iko Pharmaceutical’s revenue?

Nichi-Iko Pharmaceutical disclosed revenue of 179,060M JPY for 2022 and 188,218M JPY for 2021.

How many employees does Nichi-Iko Pharmaceutical have?

Nichi-Iko Pharmaceutical has 2,725 employees.

What sector is Nichi-Iko Pharmaceutical in?

Nichi-Iko Pharmaceutical is a medical products company.

When was Nichi-Iko Pharmaceutical founded?

Nichi-Iko Pharmaceutical was founded in 1965.

M&A Summary

  • M&A Total Activity1
    • M&A Buy Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Advisors 4

Nichi-Iko Pharmaceutical

Nichi-Iko Pharmaceutical Co., Ltd.

1-6-21 Sogawa,
Toyama, 930-8583
Japan,
81 7 6432 2121
www.nichiiko.co.jp

Nichi-Iko Pharmaceutical is a generic drug manufacturer. It has grown market share with an extensive lineup of more than 1,000 commercialized products. Nichi-Iko Pharmaceutical was founded in 1965 and is based in Toyama, Japan.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 1 - - - - - 1
vol $736M $736M
Sell (0.0/yr) # - - - - - - 0
  1

Most Recent M&A

Company Date Value Type
Sagent Pharmaceuticals, Inc. 2016-07-11 736M USD Add-on Acquisition
Schaumburg, Illinois · www.sagentpharma.com
View All >>

Business Unit M&A

Company Acquired Add-On/Sale Date #
Sagent Pharmaceuticals, Inc. 2016-07-11 Omega Laboratories Ltd. 2023-05-15 1
Schaumburg, Illinois · www.sagentpharma.com Mogadore, Ohio · www.omegalaboratory.com

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 1 (100%) 736M (100%) - -
Total 1 $736M - -

By Geo

State/Country Buy Value Sell Value
United States 1 736M - -
  Illinois 1 736M - -
Total 1 $736M - -

Top M&A Advisors

Financial Deals
J.P. Morgan Securities
1
Legal Deals
Hyman, Phelps & McNamara
1
Nishimura & Asahi
1
Paul, Weiss, Rifkind, Wharton & Garrison
1

Deal Values

buy # Total
$100M to $1B 1 $736M
TOTAL $736M
Largest Sagent Pharmaceuticals, Inc.
$736M (2016-07-11)

 Subscribe to unlock this and 208,055
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Nichi-Iko Pharmaceutical

Medical Products Companies , Japan Companies